Acelrx Pharmaceuticals Inc organizacji Cena/wartość księgowa
Jaka jest wartość Cena/wartość księgowa organizacji Acelrx Pharmaceuticals Inc?
Wartość Cena/wartość księgowa organizacji Acelrx Pharmaceuticals Inc to 13.18
Jaka jest definicja Cena/wartość księgowa?
Wskaźnik ceny do sprzedaży(Price to book ratio) reprezentuje stosunek wartości akcji spółki do wartości księgowej na akcję.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Cena/wartość księgowa firm w Health Care sektor na NASDAQ w porównaniu do Acelrx Pharmaceuticals Inc
Czym się zajmuję organizacja Acelrx Pharmaceuticals Inc?
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
Firmy z cena/wartość księgowa podobne do Acelrx Pharmaceuticals Inc
- Wartość Cena/wartość księgowa organizacji Newgen Software Technologies to 13.14
- Wartość Cena/wartość księgowa organizacji POCL Enterprises to 13.16
- Wartość Cena/wartość księgowa organizacji Magna Mining Inc to 13.17
- Wartość Cena/wartość księgowa organizacji Kirloskar Ferrous Industries to 13.17
- Wartość Cena/wartość księgowa organizacji NGL Fine-Chem to 13.17
- Wartość Cena/wartość księgowa organizacji Thangamayil Jewellery to 13.17
- Wartość Cena/wartość księgowa organizacji Acelrx Pharmaceuticals Inc to 13.18
- Wartość Cena/wartość księgowa organizacji Quartz Mountain Resources to 13.19
- Wartość Cena/wartość księgowa organizacji Atlas Copco AB to 13.19
- Wartość Cena/wartość księgowa organizacji Gufic Biosciences to 13.20
- Wartość Cena/wartość księgowa organizacji Wave Life Sciences to 13.20
- Wartość Cena/wartość księgowa organizacji MongoDB Inc to 13.20
- Wartość Cena/wartość księgowa organizacji Amber Enterprises India to 13.20